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Preeclampsia is characterized by an exaggerated
systemic inflammatory state as well as shallow pla-
centation. In the decidual implantation site , pre-
eclampsia is accompanied by an excessive number of
both macrophages and dendritic cells as well as their
recruiting chemokines, which have been implicated
in the impairment of endovascular trophoblast inva-
sion. Granulocyte-macrophage colony–stimulating fac-
tor is known to regulate the differentiation of both mac-
rophages and dendritic cells, prompting both in vivo
and in vitro evaluation of granulocyte-macrophage col-
ony-stimulating factor expression in human decidua as
well as in a mouse model of preeclampsia. This study
revealed increased granulocyte-macrophage colony–s-
timulating factor expression levels in preeclamptic de-
cidua. Moreover, both tumor necrosis factor- and in-
terleukin-1 , cytokines that are implicated in the
genesis of preeclampsia, markedly up-regulated granu-
locyte-macrophage colony-stimulating factor produc-
tion in cultured first-trimester human decidual cells.
The conditioned media of these cultures promoted the
differentiation of both macrophages and dendritic cells
from a monocyte precursor. Evaluation of a murine
model of preeclampsia revealed that the decidua of af-
fected animals displayed higher levels of immunoreac-
tive granulocyte-macrophage colony–stimulating factor
as well as increased numbers of both macrophages and
dendritic cells when compared to control animals.
Because granulocyte-macrophage colony–stimulat-
ing factor is a potent inducer of differentiation and
activation of both macrophages and dendritic cells ,
these findings suggest that this factor plays a crucial
role in the pathogenesis of preeclampsia. (Am J
Pathol 2010, 177:2472–2482; DOI: 10.2353/ajpath.2010.091247)
Implanting human blastocyst-derived extravillous cytotro-
phoblasts penetrate an underlying decidua comprised
primarily of resident decidual cells (50%) and an assort-
ment of immune cells. The extravillous cytotrophoblasts
then invade the inner myometrium during the period of
placentation. As they traverse the decidua, extravillous
cytotrophoblasts enter and transform spiral arteries and
arterioles into low-resistance, high-capacity vessels that
increase utero-placental blood flow to the developing
fetal-placental unit. In many cases of preeclampsia, a
multisystem disorder that is the single leading cause of
maternal and fetal morbidity and mortality worldwide,1
shallow decidual invasion by extravillous cytotropho-
blasts leads to incomplete vascular remodeling. The re-
sulting decreased utero-placental blood flow causes the
placenta to become relatively hypoxic2 and secretes an
array of antiangiogenic factors,2 placental debris, reac-
tive oxygen species, and proinflammatory cytokines into
the maternal circulation. The resulting systemic endothe-
lial cell activation and vascular damage leads to vaso-
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spasm, hypertension, increased platelet turnover, and a
characteristic renal lesion with proteinuria.3
Decidual immune cells promote extravillous cytotro-
phoblast invasion and confer immune tolerance of the
semiallogeneic embryo-fetal transplant.4 By contrast,
preeclampsia-related impaired extravillous cytotropho-
blast invasion is associated with local immune maladap-
tation reflecting in part excess infiltration and differentia-
tion of leukocytes that mediate innate and adaptive
immunity.3,5 In this regard, we6 and others7 observed that
decidua from preeclamptic women contains an excess of
macrophages, as well as immature and mature dendritic
cells.8 In the implantation site of uncomplicated gesta-
tions, macrophages may modulate extravillous cytotro-
phoblast invasion secondary to phagocytosis of apopto-
tic cells and remodeling of the decidua.9 However, in
preeclampsia, tumor necrosis factor- (TNF-) derived
from excess decidual macrophages is implicated in im-
pairing extravillous cytotrophoblast invasion by inducing
extravillous cytotrophoblast apoptosis and by enhanced
synthesis of plasminogen activator inhibitor-1, which in-
hibits urokinase plasminogen activator expressed at the
leading edge of trophoblast invasion. Unlike the excess
of macrophages, dendritic cell infiltration in the decidua
from preeclamptic women does not appear to impede
extravillous cytotrophoblast invasion directly.8 Alterna-
tively, in view of the strong involvement of dendritic cells
in inducing immune tolerance in other systems, the ex-
cess of dendritic cells in term decidua may account for
the high incidence of subsequent immune tolerance of
the allogeneic placenta with improved extravillous cy-
totrophoblast invasion and reduced recurrence and/or
severity of preeclampsia in subsequent pregnancies.
Colony-stimulating factors (CSFs) are secreted by di-
verse cell types and mediate unique and pleiotropic func-
tions.10 Among CSF family members, granulocyte-mono-
cyte (GM)-CSF affects survival and growth of myeloid
leukocytes. Monocytes migrate into tissues in response
to inflammatory stimuli and then differentiate into either
macrophages or immature dendritic cells.11 In vitro stud-
ies indicate that incubation with macrophage (M)-CSF
and GM-CSF transform monocytes to macrophages,
whereas GM-CSF and interleukin (IL)-4 convert mono-
cytes into immature dendritic cells.12 Mature antigen-
loaded dendritic cells migrate into peripheral lymph
nodes and activate naïve T-lymphocytes. These acti-
vated T-lymphocytes are then recruited back to the pe-
ripheral site of inflammation to mediate adaptive immune
response.
In the nonpregnant human endometrium, GM-CSF is
synthesized primarily by luminal and glandular epithelial
cells13–15 with a peak in GM-CSF mRNA levels observed
during the “window of implantation.” In contrast, the
mRNA for the GM-CSF receptor is localized to endothelial
cells of spiral arteries.16 Moreover, GM-CSF is a growth
factor for trophoblast and other placental cells.17
There are contradictory reports as to whether GM-CSF
levels are elevated in the maternal serum and placenta of
preeclamptic patients.18,19 Surprisingly, GM-CSF expres-
sion has not been assessed in decidua from preeclamp-
tic women, the crucial site of impaired extravillous cy-
totrophoblast invasion associated with local immune
maladaptation. The critical contribution of macrophages
and dendritic cells to preeclampsia-related immune mal-
adaptation at the implantation site taken together with the
importance of GM-CSF in determining the local macro-
phage and dendritic cell population emphasized the
need to address placental bed GM-CSF involvement in
the pathogenesis of preeclampsia. Major obstacles in
carrying out the research into the pathogenesis of pre-
eclampsia include: i) the late onset of clinical manifesta-
tions (usually in the third trimester), whereas the placental
pathogenesis occurs early in pregnancy; and ii) ethical
proscriptions regarding prospective obtainment of hu-
man tissues compounded by the absence of unambigu-
ous early markers that predict those women who will go
on to develop preeclampsia. Therefore, the current study
approached this question by using an integrated three-
tiered approach in which: i) In situ studies compared the
cellular immunolocalization of GM-CSF in the major cell
types of maternal-fetal interface in preeclamptic versus
gestational age-matched control decidua; ii) In vitro stud-
ies assessed the effects of preeclampsia-related proin-
flammatory cytokines on the regulation of GM-CSF ex-
pression in monolayer leukocyte-free first trimester
decidual cells,20 the predominant cell type encountered
by invading extravillous cytotrophoblasts; and iii) in vivo
studies with a mouse model of preeclampsia was used to
correlate decidual macrophage and dendritic cell infiltra-
tion with GM-CSF expression in decidual cells and the
occurrence of preeclampsia-like symptoms.
Materials and Methods
Patients’ Specimen Collections
Placental specimens were obtained from patients with
preeclampsia defined as the occurrence of elevated
blood pressure (140/90 mm Hg) and proteinuria (1
on a urine dip stick) identified on two occasions six hours
apart after 20 weeks of gestation21 in the absence of
signs and symptoms of chorioamnionitis or chronic villitis.
All cases (37– 40 weeks) were delivered by Cesarean
section without labor and specimens obtained under In-
stitutional Review Board from the Mackay Memorial Hos-
pital, Taipei, Taiwan and the University of Siena, Siena,
Italy. In Mackay Memorial Hospital, decidual tissues from
placental bed biopsies were obtained by sharp dissec-
tion of the decidua basalis about 1 to 2 cm in diameter
from the maternal surface of placenta around cord inser-
tion area following Caesarean delivery. Microscopic ex-
amination after hematoxylin and eosin stain confirmed
the identity of each issue before use. The incidence of
preeclampsia accompanied with intrauterine growth
restriction in our study population was 25% (2/8). Ges-
tational age-matched controls without labor and signs
of preeclampsia were also obtained after Cesarean
delivery. In Siena University, multiple full-thickness pla-
cental blocks were taken and histologically examined.
For each specimen, a block that best represented the
maternal decidua was selected for immunohistochem-
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istry. Tissues were snap-frozen in liquid nitrogen or
fixed in 10% buffered neutral formalin and embedded
in paraffin.
Mouse Model of Preeclampsia
Female BALB/c mice and C57BL/6 male were obtained
from BgVV or Harlan Winkelmann, Germany and main-
tained in a barrier animal facility with food and water ad
libitum and 12-hour light cycles. Animal care and exper-
imental procedures were approved by the German min-
istry and followed according to the institutional guidelines
(LaGeSo, Berlin, Germany; Reg 039/03). C57/BL6-mated
BALB/c females received either 3  107 Th1-like spleno-
cytes or PBS on gestational days 10 and 12 [preeclamp-
sia (n  9) and control (n  13)].22,23 Th1-like cell transfer
predisposed fetal rejection (Supplemental Figure 1A at
http://ajp.amjpathol.org). Blood pressure was measured
by a tail cuff method as previously described.22,23 On
gestational day 14, the mice were sacrificed. Placentae
were prepared in paraffin blocks for immunohistochem-
istry and in Trizol for total RNA isolation.
Immunohistochemistry
Human Tissues
Sections (4 m) of formalin-fixed paraffin-embedded
placenta and attached fetal membranes were cut, depar-
affinized, rehydrated, and washed in Tris-buffered saline
[TBS: 20 mmol/L Tris–HCl, 150 mmol/L NaCl (pH 7.6)].
TBS was used for all subsequent washes and for anti-
body. Antigen retrieval was carried out by incubating
sections in Target Retrieval Solution High pH (DAKO,
Copenhagen, Denmark), in a microwave oven at 750
Watts for 15 minutes. Sections were subsequently rinsed
in 3% hydrogen peroxide to block endogenous peroxi-
dase and incubated overnight at 4°C with monoclonal
antibodies against GM-CSF (R&D Systems, Minneapolis,
MN), vimentin, and cytokeratin (DAKO) diluted in TBS.
Slides were then washed three times with TBS for 5
minutes and incubated with the universal labeled strepta-
vidin biotin (LSAB) Kit (DAKO). After washing three times
for 5 minutes in TBS, sections were stained with 3,3-
diaminobenzidine tetrahydrochloride (Sigma-Aldrich, St.
Louis, MO) as chromogen substrate and counterstained
with Harris hematoxylin (Sigma-Aldrich). The reaction
was stopped by washing the sections in distilled water,
and slides were mounted and observed under a light
microscope. Staining specificity was tested by substitut-
ing monoclonal IgG isotype of anti–GM-CSF antibody
(R&D Systems) for the primary antibody. In preeclamp-
sia-associated and control placentae, positive immuno-
staining for GM-CSF was detected in virtually all of the
decidual cells. This observation mandated immunostain-
ing for GM-CSF to be quantified semiquantitatively on the
basis of staining intensity. This was carried out by a
single observer blinded to the specimens using a three-
grade scale, ranging from the most intense staining ()
to the weaker (moderate staining: ; weak staining: 0/).
For each slide, the whole decidua was assessed. Areas
were chosen at 25 magnification and each of them was
examined in-deep for semiquantitative evaluation at
200 magnification. A minimum of twelve fields were
examined for each slide.
Mouse Tissues
Immunohistochemistry was performed as previously
described24 using rat monoclonal anti–GM-CSF (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA), rabbit poly-
clonal anti-GRP94 (Imgenex, San Diego, CA), and rat
monoclonal antibody to macrophages (Abcam Inc. Cam-
bridge, MA). Briefly, 5 m formalin-fixed paraffin-embed-
ded sections were deparaffinized in xylene and rehy-
drated through a descending series of ethanol. Antigen
retrieval was then performed by boiling the slides in
citrate buffer (10 mmol/L; pH 6.0) for 15 minutes for
GRP94 and macrophage surface marker, and by incu-
bating with trypsin for 10 minutes for GM-CSF. The stain-
ing was performed according to the manufacturer’s in-
struction for Consolidate Immunohistochemistry DAB Kit
(BioGenex, San Ramon, CA) for GM-CSF and macro-
phages. For GRP94 antibody, Super Sensitive Immuno-
histochemistry Detection System for Automation Kit (Bio-
Genex, San Ramon, CA) and Rabbit Link HRP/DAB were
used. After antigen retrieval, slides were incubated with
peroxide for 5 minutes at room temperature to quench
endogenous staining according to the manufacturer’s
instructions. The slides were then incubated with Power
Block Reagent for 5 minutes at room temperature in a
humidified chamber. Excess serum was then removed,
and serial sections were incubated with anti–GM-CSF at
1:50 dilution in TBS, anti-GRP94 at 1:50 dilution in TBS,
and rat monoclonal antibody to macrophages at 1:150
dilution in TBS overnight in a humidified chamber at 4°C.
Nonspecific rabbit IgG polyclonal and rat IgG isotype
antibodies were used at the same concentrations as the
primary antibodies for negative controls. The slides were
washed 3 in TBS for 5 minutes and then incubated with
secondary antibody for 20 minutes at room temperature.
After washing in TBS, slides were incubated with strepta-
vidin-horseradish peroxidase for 20 minutes at room tem-
perature to detect the antigen-antibody complex using
3,3-diaminobenzidine tetrahydrochloride dehydrate as
chromogen. Slides were then counterstained with hema-
toxylin and mounted with Permount (Fisher Chemicals,
Springfield, NJ).
The intensity of immunostaining was semiquantitatively
evaluated using HSCORE analysis. The intensity of im-
munostaining was categorized into the following scores:
0 (no staining), 1 (weak staining), 2 (moderate staining),
and 3 (intense staining). An HSCORE value was derived
for each specimen by calculating the sum of the percent-
age of cells that stained at each intensity category mul-
tiplied by its respective intensity score, using the formula
HSCORE   Pi (i  l), where i represents the intensity
score and Pi is the corresponding percentage of cells.25
For each slide, five different fields were evaluated at
400 magnification. HSCORE evaluation was performed
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independently by two investigators blinded to the source
of the samples; the average score of both was then used.
Immunofluorescent Staining
Decidual tissues from placental bed biopsies were col-
lected under Institutional Review Board approval and
snap frozen in liquid nitrogen for cryosections (5 m in
thickness). Tissue was confirmed by hematoxylin and
eosin stain. Sections were air-dried and fixed in ice-cold
acetone for 10 minutes, then rehydrated with PBS for 5
minutes, blocked with protein block (DAKO) for 20 min-
utes, and incubated in mouse anti-human GM-CSF anti-
body diluted to 1:20 in PBS (R&D Systems) for 1 hour at
room temperature. Staining specificity was tested by sub-
stituting mouse monoclonal IgG isotype of the anti-human
GM-CSF antibody (R&D Systems) for the primary anti-
body. After three washes in PBS, sections were incu-
bated with fluorescein isothiocyanate– conjugated goat
anti-mouse antibody (1:100; Millipore; Temecula, CA) or
rabbit anti-mouse antibody (1: 100; DAKO) for 1 hour. The
sections were then washed three times and incubated in
goat anti-human vimentin antibody (1:100; Sigma-Aldrich)
or rabbit anti-human CD45 antibody (1:200; AbD Serotec,
Raleigh, NC) for 1 hour at room temperature. After three
washes in PBS, sections were incubated with rhodamine-
conjugated rabbit anti-goat antibody (1:400; Sigma-Al-
drich) or goat anti-rabbit antibody (1: 100; Millipore; Te-
mecula, CA) for 1 hour. Finally, the sections were washed
quickly in PBS three times, stained with 4,6-diamidino-
2-phenylindole (DAPI) diluted 1: 5  105 in ddH2O
(Sigma-Aldrich), and mounted in a non-fade mounting
medium (Life Sciences International, Basingstoke, UK).
Immunofluorescence was examined under a Zeiss mi-
croscope (Müchen-Hallbergmoos, Germany) equipped
with a cooled charge-coupled device camera (Axiocam
HRm, Zeiss). No cross-reaction was found between these
antibodies.
Cell Cultures
Decidual specimens from elective terminations between
6 and 12 weeks of gestation were collected under Yale
University Human Investigation Committee approval. The
villous cytotrophoblasts were dissected from the decidua
by forceps. Pulverized tissues was digested in 0.1% col-
lagenase type IV and 0.01% DNase in RPMI 1640 con-
taining 20 g/ml penicillin/streptomycin, 1 l/ml fungi-
zone) (Invitrogen Inc., Grand Island, NY) in a 37°C
shaking water bath for 30 minutes. After washing with
sterile 1 PBS, the digestate was washed  3 and sub-
jected to consecutive filtration through 100 m, 70 m,
and 40 m Millipore filters, respectively. Cells were re-
suspended in RPMI 1640 and then seeded on polysty-
rene tissue culture plates. The presence of leukocytes
after each passage was monitored by flow cytometric
analysis with anti-CD45 and anti-CD14 mAbs (BD Pharm-
ingen, San Diego, CA). Cell cultures were found to be
leukocyte-free (1%) after 3– 4 passages. Cultured de-
cidual cells were found to be vimentin-positive and cy-
tokeratin-negative and displayed decidualization-related
morphological and biochemical changes during incuba-
tion with a progestin. The latter include enhanced expres-
sion of prolactin and plasminogen activator inhibitor-1
and inhibited expression of interstitial collagenase and
stromelysin-1 and as we recently demonstrated pro-
longed up-regulation of tissue factor mRNA and protein
expression.20 Cell aliquots after harvest using trypsin/
EDTA were then frozen in fetal calf serum/DMSO (9:1)
(Sigma-Aldrich) and stored in liquid nitrogen.
Thawed first trimester decidual cells (5  105 cells per
ml) were suspended in basal medium, a phenol red-free
1:1 (vol/vol) mix of DMEM (Invitrogen, Inc.) and Ham’s
F-12 (Flow Laboratories, Rockville, MD) containing 100
U/ml penicillin, 100 g/ml streptomycin, 0.25 g/ml fun-
gizone supplemented with 10% charcoal-stripped calf
serum. The decidual cells were seeded onto polystyrene
tissue culture flasks coated with 2% type B gelatin (Sig-
ma-Aldrich), grown to confluence in a standard 95%
air:5% CO2 incubator at 37°C, and passaged  6 then
grown to confluence. Confluent decidual cells were incu-
bated for 7 days in basal medium  charcoal-stripped
calf serum containing 10	8 mol/L estradiol plus 10	7
mol/L medroxyprogesterone acetate (Sigma-Aldrich) with
one change of medium. The cultures were washed twice
with HBSS to remove residual serum components and
switched to a serum-free defined medium consisting of
basal medium plus ITS (BD Biosciences, Bedford, MA),
5 m FeSO4, 50 m ZnSO4, 1 nm CuSO4, 20 nm
Na2SeO3, trace elements (Invitrogen, Inc.), 50 g/ml
ascorbic acid (Sigma-Aldrich), and 50 ng/ml epidermal
growth factor (BD Biosciences, Bedford, MA). Subse-
quently, the cells were incubated with steroids with or
without 1 ng/ml IL-1 or TNF- for 6 hours (total RNA
purification) or 24 hours (protein extraction).
Quantitative Reverse Transcription-Polymerase
Chain Reaction (qRT-PCR)
Human Decidual Cells
The primer pairs were synthesized and gel purified at
the Yale DNA Synthesis Laboratory (Critical Technolo-
gies). Reverse transcription was initially carried out using
Omniscript kit (Qiagen, Valencia, CA) in an Eppendorf
Mastercycler Gradient (Eppendorf, Hamburg, Germany).
Each RT reaction contained 2 g of total RNA, 2 l 1x
buffer RT, 0.5 mmol/L dNTPs, 1 mol/L T7-(dT)24 oligo-
primer and 4 units of Omniscript reverse transcriptase.
This 20-l reaction was immediately incubated at 37°C
for 1 hour. Specific primer sets were designed accord-
ingly to each gene for quantitative PCR. The sequences
of these primer sets are shown in Table 1. A quantitative
standard curve was then created using a range of RT
products. The curve was created with the Roche Light
Cycler (Roche, Indianapolis, IN) by monitoring the increas-
ing fluorescence of PCR products during amplification.
Once the standard curve was established, quantification of
unknowns was determined with the Roche Light Cycler and
adjusted to the quantitative expression of -actin from these
same unknowns. Melting curve analysis was conducted to
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determine the specificity of the amplified products and the
absence of primer-dimer formation.
Murine Samples
Total RNA (2 g) was transcribed to cDNA using
dNTPs (2.5 mmol/L, Amersham, Freiburg, Germany), RB
(Moloney mouse leukemia virus), RT-buffer, DNase (2
U/l, Stratagene, Amstelveen, Netherland), and RNase
inhibitor (40 U/l, Promega, Mannheim, Germany) at
37°C for 30 minutes, then heated at 75°C for 5 minutes.
Reverse transcriptase (200 U/l) and RNase inhibitor
were added and incubated at 42°C for 1 hour, then 95°C
for 5 minutes and cooling on ice. Reactions were carried
out with 1 l cDNA, 6.5 l Sybr-Green-Mastermix (Strat-
agene), 2 l RNase-free water, 3 l primers, and 0.5 l
Fluorescein (25 nmol/L, Fermentas, St. Leon-Rot, Ger-
many) with results normalized to -actin. The sequences
of these primer sets are shown in Table 2.
ELISA
Placental Bed Biopsies
Frozen decidual tissues were homogenized in RIPA lysis
buffer (NP-40 2%, SDS 0.02%, sodium deoxycholate 1%,
1 PBS) with protease inhibitor cocktail (Sigma-Aldrich).
Total protein (25 g/ml) was used to detect the GM-CSF
levels by ELISA kit as manufacturers protocol (R&D Sys-
tems). The GM-CSF levels are expressed as pg/ml.
First Trimester Decidual Cell Cultures
Whole cell lysates prepared from cultured decidual
cells were used to measure total cell protein levels by the
Bio-Rad Assay (Bio-Rad Laboratories, Inc. Hercules,
CA). A commercial ELISA kit measured immuno-reactive
levels of GM-CSF in conditioned media according to
instructions provided by the manufacturer (R&D Sys-
tems). The ELISA has a sensitivity of 10 pg/ml. The
intra-assay and interassay coefficients of variation vary
from 2.3 to 2.6 and from 5.0 to 6.5, respectively.
Cell Differentiation Assay
Peripheral blood was collected from adult nonpregnant
healthy reproductive age female donors. The CD14
monocytes isolated from buffy coats26 using CD14 Mi-
croBeads (Miltenyi Biotec, Auburn, CA) were incubated
with conditioned media from TNF- or IL-1–treated or -un-
treated first trimester decidual cells with or without anti–GM-
CSF neutralizing antibody (R&D Systems) for 5 days. For
dendritic cell differentiation, 20 ng/ml of human recombi-
nant IL-4 (R&D Systems) was added. The identity of mac-
rophages and dendritic cells was confirmed by flow cytom-
etry using anti–CD68-PE and anti–CD11c-fluorescein
isothiocyanate antibodies (R&D Systems), respectively.
Statistical Analysis
The Kolmogorov-Smirnov one-sample test was used to
distinguish normally from nonnormally distributed results
to apply the appropriate parametric or nonparametric
tests. Tissue and cell ELISAs, immunohistochemistry,
qRT-PCR as well as cell differentiation assay results are
presented as mean 
 SEM. All parameters are ex-
pressed as mean 
 SEM. The differences were assessed
by Wilcoxon Signed Ranks test or the Student’s t-test,
when appropriate. A P value less than 0.05 was consid-
ered significant.
Results
GM-CSF Expression Is Increased in Decidua
from Preeclamptic Women
For immunostaining of formalin-fixed paraffin-embed-
ded serial sections, GM-CSF was significantly greater
in the cytoplasm of decidual cells from preeclamptic
(Figure 1B) compared with control specimens (Figure
1A). Decidual cells are identified by the positive vimen-
tin staining in control (Figure 1C) and preeclamptic
specimens (Figure 1D). Co-immunostaining of the pan-
leukocyte maker, CD45 (Figure 1, E and F), or vimentin
(Figure 1, G and H), and GM-CSF in serial frozen
sections showed that changes in GM-CSF expression
were found primarily in decidual cells, which are large
vimentin-positive CD45-negative cells. These observa-
tions were confirmed by demonstrating greater promi-
nence of yellow immunofluorescence denoting colo-
calization of GM-CSF (green) and vimentin (red) in a
preeclamptic (Figure 1H) versus gestational age-
matched control specimen (Figure 1G). Table 3 sum-
Table 1. Sequences of Primer Sets for First-Trimester Decidual Cell Cultures
Gene Forward primers Reverse primers
-Actin 5–CGTACCACTGGCATCGTGAT–3 5–GTGTTGGCGTACAGGTCTTTG–3
GM-CSF 5–AACTTCCTGTGCAACCCAGATTAT–3 5–ATGCCTGTATCAGGGTCAGTGT–3
Table 2. Sequences of Primer Sets for Mouse Placenta
Gene Forward primers Reverse primers
-Actin 5–GCTTCTTTGCAGCTCCTTCGTT–3 5–GTTGTCGACGACCAGCGC–3
GM-CSF 5–TGCGTAATGAGCCAGGAACT–3 5–TCTCGTTTGTCTTCCGCTTGT–3
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marizes the immunostaining results for the formalin-
fixed paraffin-embedded sections. It indicates that
compared with control decidual sections, decidua from
preeclamptic women more frequently displayed prom-
inent immunostaining. Consistent with the results of
immunostaining, extracts of decidual tissues from pre-
eclamptic patients contain significantly elevated levels
of immuno-reactive GM-CSF (Figure 1I) (P  0.05).
GM-CSF Expression Is Induced by IL-1 and
TNF- in Cultured First Trimester Decidual Cells
Figure 2A uses a log scale and indicates that TNF- and
IL-1 up-regulated steady state GM-CSF mRNA expres-
sion in estradiol and medroxyprogesterone acetate
primed leukocyte-free first trimester decidual cells by
20-fold (n  3, P  0.05) and 180-fold (n  5, P  0.005)
(Figure 2A), respectively. In parallel incubations, corre-
sponding effects were observed on secreted levels of
GM-CSF measured by a specific ELISA (Figure 2B). Spe-
cifically, GM-CSF expression was found to be signifi-
cantly up-regulated by TNF- and IL-1 by threefold (n 
6, P  0.05) and 123-fold (n  6, P  0.005),
respectively.
Inflammatory Cytokine-Enhanced GM-CSF
Expression by First Trimester Decidual Cells
Mediates Differentiation of Monocytes to
Macrophages and Dendritic Cells
To elucidate potential mechanism(s) by which aug-
mented GM-CSF expression by decidual cells may me-
diate the characteristic excess of macrophages and den-
dritic cells found in decidua from preeclamptic women,6,8
Figure 1. Expression of GM-CSF is increased in decidual cells from preeclamptic women. Representative serial sections for GM-CSF immunostaining of (A, 200)
gestational age (GA)-matched control and (B, 200) preeclamptic paraffin-embedded decidual tissues visualized by DAB staining. (C and D, 200) Serial sections
from corresponding tissue were stained for the decidual cell marker, vimentin. The expression of GM-CSF in decidua was also assessed by colocalization of
immunofluorescence staining of frozen sections. Yellow staining indicates colocalization of individual staining of GM-CSF (green) and (E and F, 400) CD45 (red)
or (G and H, 400) vimentin (red). The arrows indicate the large GM-CSF and vimentin double-positive cells. I: ELISA of GM-CSF expression in extracts of
decidual tissues from GA-matched and preeclamptic patients (n  8, *P  0.05).
Table 3. Immunohistochemical Analysis of Decidual
GM-CSF Expression in Preeclampsia and Control
Specimens
GM-CSF immunostaining
  0/
Preeclampsia 5 3 0
Controls 0 5 3
The following scoring system was used: , marked staining; ,
moderate staining; and 0/, weak staining.
Figure 2. TNF- and IL-1 induce GM-CSF expression in leukocyte-free
first-trimester decidual cells. A: qRT-PCR of GM-CSF in first-trimester decidual
cells treated with or without TNF- (EMT) or IL-1 (EMI). The results were
normalized to -actin. B: ELISA of GM-CSF in the conditioned media of
first-trimester decidual cells treated with or without TNF- or IL-1; the
results were normalized to total cell protein (n  3–6, *P  0.05, ***P 
0.005). The plots are shown in log scale.
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the functional role of enhanced GM-CSF expression in
first trimester decidual cells was evaluated on the differ-
entiation of monocytes to macrophages or dendritic cells.
Conditioned medium from TNF-– or IL-1–treated first
trimester decidual cells enhanced the differentiation of
monocytes isolated from peripheral blood to either mac-
rophages (CD68) (Figure 3, A–D; n  5–7, P  0.005) or
dendritic cells (CD11c) (Figure 3, E–H; n  5–9, P 
0.005) by 51–73%. Exposure to GM-CSF neutralizing an-
tibody inhibited TNF-– or IL-1–treated first trimester
decidual cell–induced monocyte differentiation to macro-
phages or dendritic cells by 51– 66% (Figure 3, A–D; n 
5–7, P  0.005 for macrophages and P  0.05 for den-
dritic cells) and 30 –32% (Figure 3, E–H; n  5 – 9, P 
0.05), respectively. These results are consistent with a
key role played by decidual cell– derived GM-CSF in the
pathogenesis of preeclampsia in view of the marked
excess of macrophages and dendritic cells in decidua
from preeclamptic women.
Murine Preeclampsia Is Associated with
Increased Decidual GM-CSF Expression as Well
as the Infiltration of Macrophages and Dendritic
Cells
Consistent with the maternal syndrome of preeclampsia
in humans, transfer of activated Th1-like splenocytes to
recipient mice elicited an immediate increase in the sys-
tolic blood pressure of recipient mice measured on ges-
tational day 14 (124 
 8 mmHg for PBS treated controls
versus 146 
 20 mm Hg for preeclamptic mice, P 
0.001) and induced proteinuria (1 g/L) in preeclamptic
mice (Supplemental Figure 1B at http://ajp.amjpathol.org).
Hematoxylin and eosin staining demonstrated extensive
edema, hemorrhage, and tissue damage in the decidual
and spongiotrophoblast layer of utero-placental units from
pregnant activated Th1-like cell recipients (preeclamptic
mice) (Figure 4, B and D) compared to controls (Figure 4, A
and C). As expected, staining of kidney sections revealed
glomeruli without histopathological change in control preg-
nant mice (Figure 4E); however, renal hemorrhage and
abnormal glomerular cell infiltration were observed in preg-
nant cell recipients (Figure 4F).
Further links between elevated GM-CSF expression in
the placenta and the onset of preeclamptic symptoms
were established by demonstrating that, compared with
control mice, recipients of activated Th1-like splenocytes
displayed augmented levels of GM-CSF mRNA (Figure
5A) and increased expression of immuno-reactive GM-
CSF (Figure 5, B, C, and H). Consistent with an increase
of macrophages and dendritic cells in the human de-
cidua from preeclamptic women, the numbers of macro-
phages (Figure 5, D, E, and I) and dendritic cells (Figure
5, F, G, and J) were also increased in the decidua of
activated Th1-like cell recipient mice.
Figure 3. The development of macrophages and dendritic cells was enhanced by TNF-– or IL-1–treated first-trimester decidual cell–derived GM-CSF.
Monocytes isolated from peripheral blood were incubated with conditioned media from leukocyte-free first-trimester decidual cells treated with estradiol 
medroxyprogesterone acetate 
 TNF- (EMT) or IL-1 (EMI) in the presence or absence of anti-human GM-CSF–neutralizing antibody (-GM-CSF). Expression
of (A–D) the macrophage (CD68) or (E–H) dendritic cell (CD11c) surface marker was examined by flow cytometric analysis (n  5–9, *P  0.05, ***P  0.005).
Histograms of flow cytometric analysis for surface marker expression are from representative experiments. Black line: EM; Short dash line: EMT; Gray line: EMT 
-GM-CSF; Dot line: EMI; Long dash line: EMI  -GM-CSF.
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Discussion
In the United States, preeclampsia complicates 5 to 10%
of pregnancies and accounts for 12 to 18% of all preg-
nancy-related maternal death.3,27 It is also a major cause
of intrauterine growth restriction (10 –25% of women with
preeclampsia) and prematurity and is associated with
various long-term neonatal morbidities.28,29 Delivery of
the placenta remits the immediate clinical manifestations
of preeclampsia and remains the only reliable treatment
for preeclampsia. However, longitudinal studies indicate
that the occurrence of preeclampsia whether treated or
not, carries severe long-term maternal health risks such
as accelerated cardiovascular death.30
While the placental pathogenesis of most cases of
preeclampsia appears to be initiated in early pregnancy
(18 –20 weeks) as a consequence of shallow extravil-
lous cytotrophoblast invasion of the decidua,31 the signs
and symptoms of preeclampsia are generally evident
much later, usually in the third trimester. The onset of
clinical manifestations reflects endothelial cell activation,
vasospasm, glomerular and hepatocyte damage, and
central nervous syndrome changes. This temporal dis-
connection between placental pathology and maternal
systemic manifestations has posed a major obstacle in
attempts to elucidate the real-time placental pathogene-
sis of this disorder or developing earlier diagnoses or
preventative therapies. Our laboratory has used a two-
tiered approach in attempting to overcome this obstacle.
Initial observations revealed that in situ observations de-
termine that numbers of macrophages as well as imma-
ture and mature dendritic cells are significantly increased
in decidual cells of preeclamptic compared with gesta-
tional age-matched decidual sections. In correspon-
dence with these increases in the two immune cell popu-
lations an array of monocyte/macrophage- and dendritic
cell-recruiting chemokines were observed to be signifi-
cantly elevated in decidua from preeclamptic women ex-
tracts as measured by ELISA and specifically in decidual
cells by immunohistochemical localization.8,32 Subse-
quently, the second tier of our approach sought to deter-
mine by in vitro studies whether expression of these pro-
teins is altered during incubation of first trimester
leukocyte-free first trimester decidual cells with pre-
eclampsia-associated proinflammatory cytokines, TNF-
and IL-1. These studies confirmed that TNF- and IL-1
each markedly increased expression of monocyte/mac-
rophage- and dendritic cell-recruiting chemokines in first
trimester decidual cells, the major resident cell type en-
countered by invading extravillous cytotrophoblasts. Pre-
vious studies from our laboratory reported parallel obser-
vations for IL-6 expression (ie, enhanced IL-6 levels were
immunolocalized to decidual cells of preeclamptic versus
control placental sections with inflammatory cytokines
augmenting IL-6 mRNA and protein expression in cul-
tured leukocyte-free first trimester decidual cells).32,33 In
several tissues, IL-6 mediates the transition from acute to
chronic inflammation by reciprocally inhibiting neutrophil
trafficking and promoting monocyte differentiation away
from dendritic cells toward macrophages.33 Taken to-
gether, previous reports from our laboratory indicate a
crucial role for decidual cells in determining the macro-
phage and dendritic cell population of the decidua from
preeclamptic women.
The pivotal role played by GM-CSF in modulating dif-
ferentiation of monocytes to macrophages and/or den-
dritic cells stimulated the current study to search for an
association between decidual cell GM-CSF expression
and preeclampsia-related trafficking of both immune cell
types. Previously, decidual GM-CSF was shown to origi-
nate from T-lymphocytes responding to alloantigens,34
whereas GM-CSF expression was not assessed in de-
cidua from preeclamptic women. Seeking to fill in this
gap in our knowledge, the current study found that: i)
immuno-reactive GM-CSF levels are elevated in decidual
cells of placental sections of patients with preeclampsia
versus gestational-age matched controls; ii) GM-CSF
mRNA and protein levels are enhanced in first trimester
decidual cells during incubation with the preeclampsia-
related inflammatory cytokines, TNF- and IL-1. These
observations, taken together with the well-documented
roles of macrophages and dendritic cells in preeclamp-
sia-related events as detailed above as well as those of
GM-CSF in activating both macrophages and dendritic
cells, strongly suggest that decidual cell– derived GM-
CSF plays a regulatory role in the early pathogenesis of
preeclampsia. Studies from our6 and other laboratories35
observed an increase in macrophages in the decidua of
women with preeclampsia. In vitro observations indicate
that macrophage-derived TNF- inhibits extravillous cy-
Figure 4. Histopathological changes in the utero-placental units and kid-
neys in preeclamptic mice. Eight-week-old female BALB/c mice mated with
male C57BL/6 mice were injected with either PBS or 3  107 activated
Th1-like splenocytes isolated from spleen on gestational days 10 and 12.
Samples were collected at gestational day 14. The paraffin-embedded utero-
placental units and kidneys were stained with hematoxylin and eosin. A
(100) and C (400): The tissue was intact in placenta from PBS-injected
mice. B (100) and D (400): Extensive edema (black arrows) and hem-
orrhage (black arrowhead) were found in the spongiotrophoblast layer of
placenta from activated Th1-like cell recipient. E (200): No histopatholog-
ical change was found in the kidney from PBS-injected mice. F (200):
Hemorrhage (white arrowhead) and increase of cell infiltration (white
arrows) in glomeruli were shown in the kidney from an activated Th1-like
cell recipient.
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totrophoblast invasion by inducing apoptosis in extravil-
lous trophoblasts, thereby interfering with extravillous cy-
totrophoblast-mediated decidual vascular remodeling to
produce the characteristic placental hypoxia and mater-
nal symptoms of preeclampsia. This effect was
blocked by an antibody against the TNF- receptor,35
whereas inhibition of extravillous cytotrophoblast inva-
siveness by lipopolysaccharide-activated macrophages
was reversed by a TNF- neutralizing antibody.36 Medi-
ating this process by decidual cells was indicated by our
observations that macrophages incubated with condi-
tioned medium from IL-1–treated first trimester human
decidual cells inhibited extravillous cytotrophoblast inva-
sion. A report from our laboratory was the first to demon-
strate a preeclampsia-related increase in decidual den-
dritic cells.8 However, dendritic cells incubated with
conditioned medium from IL-1–treated first trimester hu-
man decidual cells did not impede extravillous cytotro-
phoblast invasion. Ongoing work in our laboratory sug-
gests that the preeclampsia-related infiltration of
dendritic cells into the decidua may induce a compen-
satory immune tolerance consistent with the reduced
incidence and severity of preeclampsia in subsequent
pregnancies. In vitro experiments are needed to deter-
mine whether co-incubation with either macrophages
or dendritic cells in fact induces apoptotic changes in
extravillous cytotrophoblasts.
While use of the two-tiered approach to include GM-
CSF in the current study has provided important insights
into the pathogenesis of preeclampsia, we sought to
extend this to a third tier by evaluating decidual expres-
sion of GM-CSF in a mouse model of preeclampsia. In
particular, studies from the laboratory of Croy and asso-
ciates have revealed similarities in implantation and pla-
centation as well as the uterine immune cell population
between the mouse and human.37 A growing body of
evidence shows that mouse models provide important
clues that have aided investigators in identifying proteins
that are required to coordinate embryo and maternal
interactions during the peri-implantation period. The use
of this specific mouse model allowed us to investigate
whether dendritic cell and GM-CSF expressed in den-
dritic cell may be related to the preeclampsia-like symp-
toms observed exclusively in pregnant mice25,26 after
transfer of activated Th1 cells. Such information has clear
implications in elucidating the pathogenesis of pre-
eclampsia.38,39 Specifically, the current study found that
mice induced to exhibit preeclamptic symptoms (ie, pro-
teinuria and hypertension) displayed elevated decidual
GM-CSF expression together with significant macro-
phage and dendritic cell infiltration of the decidua.
Although several reports indicate that circulating IL-1
and TNF- levels are elevated in women with preeclamp-
sia, the source of these increases is unclear. However,
Figure 5. The numbers of macrophages and dendritic cells as well as the expression of
GM-CSF were increased in the decidua from preeclamptic mice. A: GM-CSF mRNA
expression in placenta by qRT-PCR. The plot is shown in log scale. Th1-like cell transfer
induced GM-CSF expression in the preeclamptic decidua. GM-CSF expression in the
placenta from control (CON; B) and preeclamptic (PE; C) mice, macrophages (Ms) in
the placenta from control (D) and preeclamptic (E) mice. Dendritic cells (DCs) in the
placenta from control (F) and preeclamptic (G) mice. Magnification, 400. H: H-score
comparison of GM-CSF staining between control and preeclamptic decidua (n  7, ***P 
0.005). I: Comparison of the number of macrophages between control and preeclamptic
decidua (n  7, **P  0.01). J: Comparison of the number of dendritic cells between
control and preeclamptic decidua (n  7, *P  0.05). Five different fields per sample
were evaluated.
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these changes appear to represent exaggeration of the
normal peri-implantational decidual macrophage infiltra-
tion. Compared with levels of IL-1, the follicular and
peri-ovulatory phase human endometrium contains a 10-
to 30-fold excess of IL-1 receptor antagonist (IL-1Ra),
which blocks the IL-1 receptor. A decline in glandular
IL-1Ra levels coincides with the “window of implanta-
tion.”40 Observations in our laboratory suggest that the
resulting free IL-1 enhances expression of several
monocyte recruiting and activating chemokines in decid-
ual cells that promote a physiological monocyte influx
during early gestation but is normally transient because
extravillous cytotrophoblasts release IL-1Ra.41,42 How-
ever, increased expression of IL-1 in significant subsets
of preeclampsia cases accompanying maternal infec-
tions, such as Chlamydia43,44 and viruses,45,46 and other
inflammatory states may overwhelm this block of the
IL-1R by IL-1Ra. In addition, TNF- and IL-1 polymor-
phisms are associated with impaired extravillous cytotro-
phoblast invasion, preeclampsia, and eclampsia.47–51
Elevated levels of TNF- or IL-1 associated with inflam-
matory states or maternal genetic polymorphisms target
decidual cells to enhance synthesis and secretion of mono-
cyte/macrophage- and dendritic cell-recruiting chemokines
and CSFs to enhance recruitment/differentiation/activa-
tion of macrophages and dendritic cells. Because mac-
rophages are a rich source of TNF-, the concerted
actions of IL-1 and macrophage-derived TNF- may
promote a feed-forward cycle to promote an excess of
decidual macrophages in preeclampsia. The resulting
impaired extravillous cytotrophoblast invasion and in-
complete remodeling of the spiral arteries which de-
creases utero-placental blood flow to produce placental
hypoxia. That hypoxia-reoxygenation enhances output of
TNF- in human placental tissue52 suggests that the pla-
centa is an additional source of TNF-.
In summary, the current use of a three-tier approach
(ie, in situ and in vivo measurements in human decidual
cells followed by in vivo confirmation) in the decidua of a
mouse model for preeclampsia suggests that elevated
GM-CSF expression plays an integral role in the patho-
genesis of preeclampsia. Future studies that use GM-
CSF null mice and extend the strategy used in the current
study to include other preeclampsia-associated proteins
offer great promise in making strides in the diagnosis and
treatment of this major pathology of human pregnancy.
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